HT’s National Facilities Invite Expressions of Interest for Large-Scale Genomics Projects
Human Technopole’s National Facilities are inviting Expressions of Interest (EoI) to access Whole Genome Sequencing and Analysis services for large-scale population genomics studies in the biomedical field.
Human Technopole’s National Facilities: New Call Following 147% Surge in Proposals
Human Technopole has opened a new Call for Access to its National Facilities on 1 February 2026, offering researchers from Italy the opportunity to access cutting-edge technologies and expertise across the institute’s advanced research platforms.
FRRB funds the Glastonbury Group to study the immune landscape of pancreatic cancer
The Glastonbury Group at Human Technopole has been awarded a competitive grant as part of the “From Bed To Bench: the way to innovation” funding programme promoted by the Fondazione Regionale per la Ricerca Biomedica (FRRB). The study, funded with 2.000.000 euros, 600.000 of which will go to the Glastonbury group directly, will begin in late 2025 and run for 3 years.
HT National Facilities: Upcoming Call for Access 2025 – Round 2
On 27 and 28 March, the SIEC (Standing Independent Evaluation Committee), visited HT to discuss the results of the first call for access, which was considered a pilot phase, and refine the upcoming call, planned to be published at the beginning of June 2025.
Advancing Precision Immunotherapy for Paediatric Leukaemia with Alice Giustacchini and her Group
Meet Alice Giustacchini, Research Group Leader in Population and Medical Genomics. Her project, titled “Tailoring Precision Immunotherapy to Paediatric Acute Myeloid Leukaemia,” aims to study the cellular and molecular dynamics of CAR-T cell therapy in blood cancers.
Previous page